In last trading session, Mural Oncology plc (NASDAQ:MURA) saw 0.59 million shares changing hands with its beta currently measuring 3.67. Company’s recent per share price level of $3.89 trading at $0.24 or 6.58% at ring of the bell on the day assigns it a market valuation of $66.36M. That closing price of MURA’s stock is at a discount of -51.16% from its 52-week high price of $5.88 and is indicating a premium of 26.22% from its 52-week low price of $2.87. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.22 million shares which gives us an average trading volume of 164.23K if we extend that period to 3-months.

For Mural Oncology plc (MURA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -1.98 in the current quarter.

Mural Oncology plc (NASDAQ:MURA) trade information

Upright in the green during last session for gaining 6.58%, in the last five days MURA remained trading in the green while hitting it’s week-highest on Friday, 01/10/25 when the stock touched $3.89 price level, adding 2.75% to its value on the day. Mural Oncology plc’s shares saw a change of 20.81% in year-to-date performance and have moved 21.56% in past 5-day. Mural Oncology plc (NASDAQ:MURA) showed a performance of -2.51% in past 30-days. Number of shares sold short was 0.41 million shares which calculate 3.85 days to cover the short interests.

Mural Oncology plc (MURA) estimates and forecasts

Statistics highlight that Mural Oncology plc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 18.96% of value to its shares in past 6 months, showing an annual growth rate of 39.34% while that of industry is 16.60. Apart from that, the company came raising its revenue forecast for fiscal year 2025.

On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 520.28 shares of worth $2.02 million or 3.06% of the total outstanding shares. The later fund manager was in possession of 236.78 shares on Sep 30, 2024 , making its stake of worth around $0.92 million in the company or a holder of 1.39% of company’s stock.